1400 16th Street
San Francisco, CA 94103
United States
415 374 7782
https://www.invitae.com
版塊: Healthcare
行業: Diagnostics & Research
全職員工: 1,700
名稱 | 頭銜 | 支付 | 行使價 | 出生年份 |
---|---|---|---|---|
Dr. Randal W. Scott Ph.D. | Co-Founder & Chairman of the Board | 50k | 無 | 1958 |
Mr. Kenneth D. Knight | President, CEO & Director | 1.4M | 無 | 1961 |
Mr. Thomas R. Brida | General Counsel, Chief Compliance Officer & Secretary | 776.72k | 無 | 1971 |
Ms. Ana J. Schrank | Chief Accounting Officer & CFO | 無 | 無 | 1966 |
Dr. David B. Sholehvar M.D. | Chief Operating Officer | 無 | 無 | 1968 |
Ms. Hoki Luk | Head of Investor Relations and Capital Markets & Corporate Development | 無 | 無 | 1976 |
Ms. Shelly D. Guyer | Chief Sustainability Officer | 430.44k | 無 | 1960 |
Ms. Desarie French | Chief Talent Officer | 無 | 無 | 無 |
Dr. W. Michael Korn M.D. | Chief Medical Officer | 無 | 無 | 無 |
Mr. Robert Guigley | Chief Commercial Officer | 無 | 無 | 無 |
Invitae Corporation, a medical genetics company, that provides genetic information to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, precision oncology, women's health, rare diseases, and pharmacogenomics; digital health solutions; and health data services. It serves patients, healthcare providers, biopharma companies, and other partners. The company was formerly known as Locus Development, Inc. and changed its name to Invitae Corporation in 2012. Invitae Corporation was incorporated in 2010 and is headquartered in San Francisco, California. On February 13, 2024, Invitae Corporation, along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of New Jersey.
截至 2024年5月1日 止,Invitae Corporation 的 ISS 管治質素評分為 9。 Pillar 分數正在審核中:5;董事會:10;股東權利:7;現金賠償:9。